Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1092 | Pituitary and Neuroendocrinology 3 | ECE2019

Factors predicting dopamine agonist treatment withdrawal in prolactinoma patients

Solak Mirsala , Haxhiu Arta , Haxhiu Arita , Kraljevic Ivana , Dusek Tina , Leskovar Dunja , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

Aim: Dopamine agonist (DA) therapy is recommended as first-line treatment for prolactinomas, albeit with long treatment duration and high recurrence rate after treatment withdrawal. The aim of this retrospective study was to evaluate predictors for successful DA withdrawal.Methods: The study included 59 prolactinoma patients (39 female, 20 male; age 34 (18–82) years) that were treated with DA (35.6% on cabergoline); the duration of treatment was 71 ...

ea0049ep71 | Adrenal cortex (to include Cushing's) | ECE2017

Neutrophil-lymphocyte and platelet-lymphocyte ratios as biomarkers in distinguishing adrenocortical adenomas and carcinomas

Solak Mirsala , Kraljevic Ivana , Kastelan Marko , Kakarigi Luka , Dusek Tina , Polovina Tanja Skoric , Balasko Annemarie , Knezevic Nikola , Kastelan Darko

The role of systemic inflammation in promoting tumor progression has been a topic of increasing interest. Neutrophil-lymphocyte ratio (NLR) >5 and platelet-lymphocyte ratio (PLR) >190 used as indicators of inflammation have been reported to have prognostic value in numerous solid tumors. The aim of this retrospective study was to investigate NLR and PLR as biomarkers in distinguishing between adrenocortical adenomas and adrenocortical carcinomas (ACC). Nineteen patient...

ea0037ep817 | Pituitary: clinical | ECE2015

Management of Cushing's disease: single centre experience

Solak Mirsala , Kraljevic Ivana , Dusek Tina , Melada Ante , Kavanagh Marcel Marjanovic , Peterkovic Vjerislav , Ozretic David , Kastelan Darko

Introduction: Cushing’s disease (CD) is an uncommon condition of excess endogenous glucocorticoids caused by ACTH secreting pituitary corticotroph adenoma. The purpose of this study is to review therapeutic outcomes and comorbidity of patients with CD in a single centre.Methods: We conducted a retrospective study of 33 patients with CD undergoing transsphenoidal surgery from January 2007 to February 2014. (27 female and six male, median age 38 years...

ea0026p214 | Pituitary | ECE2011

Multimodal treatment and minimally invasive surgery for 117 pituitary adenomas: a Croatian Pituitary Centre experience

Kruljac Ivan , Maric Andreja , Sulentic Petra , Cigrovski Maja Berkovic , Mahecic Davorka Herman , Mirosevic Gorana , Kastelan Darko , Vrkljan Milan

Studies that consolidate the results of medicamentous and surgical treatment of pituitary adenomas are scarce. Pure endoscopic endonasal transsphenoidal surgery is rather new technique.The aim of this study is to report on early postoperative outcome of pure endoscopic endonasal transsphenoidal surgery and to present the results of multimodal treatment in patients with postsurgical failure.We reviewed 117 consecutive patients who u...

ea0056p855 | Pituitary - Clinical | ECE2018

Hypopituitarism in primary empty sella

Tomsic Karin Zibar , Deskin Marin , Kraljevic Ivana , Dusek Tina , Solak Mirsala , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

Empty sella is characterized by the radiological appearance of an enlarged or deformed sella turcica which is completely or partially filled with cerebrospinal fluid resulting in a displacement of the normal pituitary gland. Primary empty sella (PES) refers to the empty sella appearance of unknown etiology, diagnosed after excluding a history of previous pituitary pathology. The prevalence of hypopituitarism in empty sella syndrome varies between 2 and 32% in different publish...

ea0099p241 | Adrenal and Cardiovascular Endocrinology | ECE2024

Treatment outcomes in patients with recurrent adrenocortical carcinoma

Dojcinovic Tamara , Tomšić KarinZibar , Vodanović IvanaDora , Kraljevic Ivana , Nekic AnjaBarac , Polovina TanjaSkoric , Kastelan Darko

Background: While a considerable body of literature exists detailing outcomes in patients with adrenocortical carcinoma (ACC), reports specifically addressing a cohort of patients with recurrent disease remain scarce. Therefore, the objective of this study was to evaluate treatment outcomes in patients with recurrent ACC.Methods: In our cohort of 55 patients who underwent R0/Rx tumor resection between 2011 and 2022, 18 individuals (33%) exhibited recurre...

ea0099ep29 | Calcium and Bone | ECE2024

The usefulness of 18F-choline PET/CT in patients with negative findings on 99mTc-sestamibi SPECT/CT in Locating Hyperfunctioning Parathyroid Glands in Primary Hyperparathyroidism

Mandic Ante , Kraljevic Ivana , Skoric Polovina Tanja , Zibar Tomsic Karin , Dusek Tina , Balasko Annemarie , Solak Mirsala , Kastelan Darko

Objective: This study aimed to investigate the diagnostic performance of 18F-choline PET/CT in patients with negative or inconclusive results of 99mTc-sestamibi SPECT/CT in locating hyperfunctioning parathyroid tissue in primary hyperparathyroidism patients.Methods: We conducted a retrospective study involving patients who were operated on due to primary hyperparathyroidism from April 2019 to March 2022. The analysis focused on pati...

ea0099ep140 | Pituitary and Neuroendocrinology | ECE2024

Long-term outcomes of non-functioning pituitary macroadenomas following surgery

Solak Mirsala , Kraljevic Ivana , Brekalo Roman , Skoric Polovina Tanja , Balasko Annemarie , Zibar Tomsic Karin , Popovac Hrvoje , Dusek Tina , Kastelan Darko

Background: Systematic or randomised studies on the natural course of non-functioning pituitary macroadenomas after surgery (NFPA) are lacking.Objectives: This study aimed to evaluate the long-term outcomes of residual NFPA following pituitary surgery.Methods: In this retrospective study, we included 130 patients with NPFA who underwent pituitary surgery between 2005 and 2018 at University Hospital Centre Zagreb. The median age of ...

ea0081p264 | Adrenal and Cardiovascular Endocrinology | ECE2022

Mitotane side effects in the treatment of patients with adrenocortical carcinoma - a retrospective study

Barac Nekic Anja , Zibar Tomšić Karin , Sambula Lana , Matas Nino , Jambrović Martina , Petrak Iva , Dusek Tina , Kastelan Darko

Introduction: Mitotane is widely used to treat adrenocortical carcinoma (ACC) and remains the mainstay of treatment along with surgery. The aim of this study is to evaluate the adverse side effects of mitotane treatment.Materials and Methods: This retrospective study included 36 patients with ACC, ENSAT stage I- IV, who were treated with mitotane in an adjuvant or palliative setting. Patients with ENSAT stage IV who died within 6 months after surgery wer...

ea0081p694 | Pituitary and Neuroendocrinology | ECE2022

Radiological classification of craniopharyngioma based on its origin

Skoric Polovina Tanja , Ozretic David , Solak Mirsala , Kraljevic Ivana , Dusek Tina , Balasko Annemarie , Zibar Tomšić Karin , Kastelan Darko

Recognizing the site of origin of craniopharyngioma (CP) along the hypothalamus-pituitary axis according to pre-operative MR is helpful to understand its growth pattern in relation to hypothalamus, which is critical in the prediction of hypothalamic injury and planning of treatment. We retrospectively classified 29 CP according to MR pre-operative image study using modified classification of Tang et al. (Nature, 8:10215, 2018). According to its relation to pituitary s...